earnings

AbbVie Shareholders Have a Lot to Look Forward To With Allergan
AbbVie Shareholders Have a Lot to Look Forward To With Allergan
Motley Fool
AbbVie
Allergan
earnings
M&A
Flag link:
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much
Fierce Pharma
earnings
Big Pharma
AstraZeneca
Merck
Celgene
Novartis
Novo Nordisk
Pfizer
Flag link:
Merck KGaA posts higher profit and revenue as it lifts sales forecast
Merck KGaA posts higher profit and revenue as it lifts sales forecast
Marketwatch
Merck KGaA
earnings
Flag link:
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
Yahoo/Zacks.com
earnings
biotech
Eyenovia
SAGE Therapeutics
AC Immune
Ascendis
NGM Biopharmaceuticals
Flag link:
Why Sarepta Therapeutics' Q3 Was Better Than Expected
Why Sarepta Therapeutics' Q3 Was Better Than Expected
Motley Fool
Sarepta Therapeutics
earnings
Flag link:
Only 1 Number Mattered in Arena Pharmaceuticals' Q3 Results -- and It Was Big
Only 1 Number Mattered in Arena Pharmaceuticals' Q3 Results -- and It Was Big
Motley Fool
Arena Pharmaceuticals
earnings
Flag link:
Pharma Giant Teva Reported Lagging Earnings — Here's Why Shares Rallied
Pharma Giant Teva Reported Lagging Earnings — Here's Why Shares Rallied
Investors Business Daily
Teva Pharmaceutical
earnings
Flag link:
Zimmer Biomet Holdings Inc. Q3 adjusted earnings Beat Estimates
Zimmer Biomet Holdings Inc. Q3 adjusted earnings Beat Estimates
NASDAQ
Zimmer Biomet
earnings
devices
Flag link:
Tardy marketing application filing, trial failure troubles Supernus investors
Tardy marketing application filing, trial failure troubles Supernus investors
Endpoints
Supernus
earnings
ADHD
SPN-812
SPN-810
clinical trials
Flag link:
Regeneron Pharmaceuticals Earnings: REGN Stock Rockets 7% on Q3 Beat
Regeneron Pharmaceuticals Earnings: REGN Stock Rockets 7% on Q3 Beat
Investor Place
Regeneron
earnings
Flag link:
Amarin (AMRN) Beats Earnings & Revenues Estimates in Q3
Amarin (AMRN) Beats Earnings & Revenues Estimates in Q3
Zacks.com
Amarin
earnings
Flag link:
Allergan (AGN) Q3 Earnings Meet Estimates
Allergan (AGN) Q3 Earnings Meet Estimates
Yahoo/Zacks.com
Allergan
earnings
Flag link:
Regeneron profit beats expectations on Eylea, Dupixent strength
Regeneron profit beats expectations on Eylea, Dupixent strength
Yahoo/Reuters
Regeneron
earnings
Eylea
Dupixent
Flag link:
Novo Nordisk (NVO) Q3 Earnings Beat Estimates, Revenues Miss
Novo Nordisk (NVO) Q3 Earnings Beat Estimates, Revenues Miss
Yahoo/Zacks.com
Novo Nordisk
earnings
Flag link:
3 Most Important Takeaways From AbbVie's Q3 Results
3 Most Important Takeaways From AbbVie's Q3 Results
Motley Fool
AbbVie
earnings
Humira
Imbruvica
Flag link:
Biopharma Q3: Pfizer, Merck, Amgen, Incyte and J&J
Biopharma Q3: Pfizer, Merck, Amgen, Incyte and J&J
BioSpace
earnings
Pfizer
Merck
Amgen
Incyte
JNJ
Flag link:
WIll Allergan (AGN) Beat Estimates This Earnings Season?
WIll Allergan (AGN) Beat Estimates This Earnings Season?
Yahoo/Zacks.com
Allergan
earnings
Flag link:
Why Earnings Season Could Be Great for Neurocrine Biosciences (NBIX)
Why Earnings Season Could Be Great for Neurocrine Biosciences (NBIX)
Yahoo/Zacks.com
Neurocrine Biosciences
earnings
Flag link:
AbbVie (ABBV) Beats on Q3 Earnings & Sales, Tweaks EPS View
AbbVie (ABBV) Beats on Q3 Earnings & Sales, Tweaks EPS View
Yahoo/Zacks.com
AbbVie
earnings
Flag link:
Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish Line
Bristol-Myers Squibb Beats Expectations in Q3 as Its Celgene Acquisition Nears the Finish Line
Motley Fool
Bristol-Myers Squibb
earnings
Flag link:

Pages